These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 15493113)

  • 61. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?
    Baker JF; Krishnan E; Chen L; Schumacher HR
    Am J Med; 2005 Aug; 118(8):816-26. PubMed ID: 16084170
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Uric acid, the kidney and cardiovascular mortality].
    Santoro A; Mandreoli M
    G Ital Nefrol; 2015; 32 Suppl 62():. PubMed ID: 26005872
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A multicenter study of the association of serum uric acid, serum creatinine, and diuretic use in hypertensive patients.
    Lin CS; Hung YJ; Chen GY; Tzeng TF; Lee DY; Chen CY; Huang WP; Huang CH
    Int J Cardiol; 2011 May; 148(3):325-30. PubMed ID: 20053470
    [TBL] [Abstract][Full Text] [Related]  

  • 64. AT1 blockers and uric acid metabolism: are there relevant differences?
    Puig JG; Torres R; Ruilope LM
    J Hypertens Suppl; 2002 Jun; 20(5):S29-31. PubMed ID: 12184060
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk.
    Bandukwala F; Huang M; Zaltzman JS; Nash MM; Prasad GV
    Am J Cardiol; 2009 Mar; 103(6):867-71. PubMed ID: 19268747
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hyperuricaemia: more than just a cause of gout?
    Katsiki N; Karagiannis A; Athyros VG; Mikhailidis DP
    J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):397-402. PubMed ID: 23032963
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed.
    Kanellis J; Feig DI; Johnson RJ
    Nephrology (Carlton); 2004 Dec; 9(6):394-9. PubMed ID: 15663643
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Contribution of the CoLaus study to decipher the determinants of serum uric acid].
    Bochud M; Vollenweider P; Waeber G
    Rev Med Suisse; 2011 Nov; 7(315):2142, 2144-5. PubMed ID: 22187784
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Association of hyperuricemia with renal outcomes, cardiovascular disease, and mortality.
    Liu WC; Hung CC; Chen SC; Yeh SM; Lin MY; Chiu YW; Kuo MC; Chang JM; Hwang SJ; Chen HC
    Clin J Am Soc Nephrol; 2012 Apr; 7(4):541-8. PubMed ID: 22300737
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Diabetes: Lowering serum uric acid levels to prevent kidney failure.
    Doria A; Krolewski AS
    Nat Rev Nephrol; 2011 Aug; 7(9):495-6. PubMed ID: 21808278
    [No Abstract]   [Full Text] [Related]  

  • 71. [The uric acid cardio-nephropathy].
    Viazzi F; Bonino B; Cappadona F; Pontremoli R
    G Ital Nefrol; 2017 Mar; 34(Suppl 69):41-48. PubMed ID: 28682028
    [TBL] [Abstract][Full Text] [Related]  

  • 72. What is the effect on cardiovascular events of reducing hyperuricemia with allopurinol? An evidence-based review.
    Guedes M; Esperança A; Pereira AC; Rego C
    Rev Port Cardiol; 2014 Nov; 33(11):727-32. PubMed ID: 25444231
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease.
    Johnson RJ; Kivlighn SD; Kim YG; Suga S; Fogo AB
    Am J Kidney Dis; 1999 Feb; 33(2):225-34. PubMed ID: 10023633
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hyperuricemia and chronic kidney disease: an enigma yet to be solved.
    Dousdampanis P; Trigka K; Musso CG; Fourtounas C
    Ren Fail; 2014 Oct; 36(9):1351-9. PubMed ID: 25112538
    [TBL] [Abstract][Full Text] [Related]  

  • 75. URAT1 gene polymorphisms influence uricosuric action of losartan in hypertensive patients with hyperuricemia.
    Sun H; Qu Q; Qu J; Lou XY; Peng Y; Zeng Y; Wang G
    Pharmacogenomics; 2015 Jul; 16(8):855-63. PubMed ID: 26086348
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Serum uric acid and cardiovascular risk: state of the art and perspectives.
    Fenech G; Rajzbaum G; Mazighi M; Blacher J
    Joint Bone Spine; 2014 Oct; 81(5):392-7. PubMed ID: 24565888
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hyperuricemia and Hypertension, Coronary Artery Disease, Kidney Disease: From Concept to Practice.
    Gaubert M; Bardin T; Cohen-Solal A; Diévart F; Fauvel JP; Guieu R; Sadrin S; Maixent JM; Galinier M; Paganelli F
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 33561034
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project.
    Maloberti A; Giannattasio C; Bombelli M; Desideri G; Cicero AFG; Muiesan ML; Rosei EA; Salvetti M; Ungar A; Rivasi G; Pontremoli R; Viazzi F; Facchetti R; Ferri C; Bernardino B; Galletti F; D'Elia L; Palatini P; Casiglia E; Tikhonoff V; Barbagallo CM; Verdecchia P; Masi S; Mallamaci F; Cirillo M; Rattazzi M; Pauletto P; Cirillo P; Gesualdo L; Mazza A; Volpe M; Tocci G; Iaccarino G; Nazzaro P; Lippa L; Parati G; Dell'Oro R; Quarti-Trevano F; Grassi G; Virdis A; Borghi C;
    High Blood Press Cardiovasc Prev; 2020 Apr; 27(2):121-128. PubMed ID: 32157643
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Uric acid and cardiovascular disease: A clinical review.
    Saito Y; Tanaka A; Node K; Kobayashi Y
    J Cardiol; 2021 Jul; 78(1):51-57. PubMed ID: 33388217
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Uric acid as a cardiometabolic risk factor: to be or not to be.
    Kanbay M; Afsar B; Covic A
    Contrib Nephrol; 2011; 171():62-67. PubMed ID: 21625091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.